These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Bioresorbable vascular scaffold restenosis: intravascular imaging evaluation. Fabris E; Kilic ID; Caiazzo G; Serdoz R; Foin N; Sinagra G; Di Mario C J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e132-e135. PubMed ID: 26599682 [TBL] [Abstract][Full Text] [Related]
6. Severe Neointimal Hyperplasia of Neoplastic Carina Following Bioresorbable Scaffold Implantation Using T-Stenting and Small Protrusion Technique: Insights From Optical Frequency Domain Imaging. Kawamoto H; Ruparelia N; Figini F; Latib A; Colombo A JACC Cardiovasc Interv; 2015 Nov; 8(13):e207-9. PubMed ID: 26476605 [No Abstract] [Full Text] [Related]
7. Drug-coated balloon for recurrent in-stent restenosis treatment: A suitable strategy. Piraino D; Buccheri D; Cimino G; Andolina G Int J Cardiol; 2016 Oct; 221():1084-6. PubMed ID: 27448537 [No Abstract] [Full Text] [Related]
8. Early Collapse of a Magnesium Bioresorbable Scaffold. Cubero-Gallego H; Vandeloo B; Gomez-Lara J; Romaguera R; Roura G; Gomez-Hospital JA; Cequier A JACC Cardiovasc Interv; 2017 Sep; 10(18):e171-e172. PubMed ID: 28935085 [No Abstract] [Full Text] [Related]
9. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel. Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654 [No Abstract] [Full Text] [Related]
11. Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation. Indolfi C; Mongiardo A; Spaccarotella C; Caiazzo G; Torella D; De Rosa S Circ Cardiovasc Imaging; 2014 Jul; 7(4):755-7. PubMed ID: 25027457 [No Abstract] [Full Text] [Related]
12. Restenosis of Coronary Bioresorbable Vascular Scaffolds. Alfonso F; García-Guimaraes M Rev Esp Cardiol (Engl Ed); 2017 Jul; 70(7):527-531. PubMed ID: 28285939 [No Abstract] [Full Text] [Related]
13. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Serruys PW; Onuma Y; Ormiston JA; de Bruyne B; Regar E; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Miquel-Hebert K; Rapoza R; García-García HM Circulation; 2010 Nov; 122(22):2301-12. PubMed ID: 21098436 [TBL] [Abstract][Full Text] [Related]
15. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up. Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536 [TBL] [Abstract][Full Text] [Related]
16. Rotational Atherectomy Combined With Bioresorbable Vascular Scaffold Implantation: A Feasible Approach for Recurrent In-stent Restenosis When Other Therapies Failed. Pereira-da-Silva T; Patrício L; Cruz Ferreira R J Invasive Cardiol; 2015 Jul; 27(7):E143-5. PubMed ID: 26136289 [TBL] [Abstract][Full Text] [Related]
17. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results. Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932 [TBL] [Abstract][Full Text] [Related]
18. Fully bioresorption of an Absorb bioresorbable vascular scaffold after scaffold restenosis. Goncalves-Ramírez LR; Gutiérrez H; Rojas P; Cortés C; Serrador A; Ramos B; Toro J; Amat-Santos IJ; San Román JA Cardiol J; 2019; 26(2):209-211. PubMed ID: 31032876 [No Abstract] [Full Text] [Related]
19. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study. Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728 [TBL] [Abstract][Full Text] [Related]
20. Late Malapposition After Bare-Metal Stent, But Not Bioresorbable Scaffold: Insights on Intraindividual Heterogeneity in Plaque and Device Response. Cortese B; Buccheri D; Silva Orrego P; Biondi-Zoccai G J Invasive Cardiol; 2015 Aug; 27(8):E171-2. PubMed ID: 26232021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]